Move to main content
Euformatics logo
  • Frontpage
  • Genomics Hub
    • Sample Quality ControlView your operational quality with clarity
    • Gene Test ValidationQuickly validate your pipeline
    • Variant InterpretationRelevant variants and reports within minutes
  • Full Stack AI
  • News
  • About us
    • Our mission
    • Team
  • Careers
  • Contact us
  • Book a demo
Book a demo
News

Press releases & blog posts

Show AllEuformatics BlogFeature updateNews

PRESS RELEASE | Euformatics receives funding from Recovery and Resilience Facility for the research and development of advanced NGS software and inter-laboratory quality control tools

1.7.2022

ESPOO, Finland, July 1st 2022. Finnish IT company Euformatics has been awarded a grant from the European Commission’s Recovery and Resilience

Read more

PRESS RELEASE | Euformatics partners with BC Platforms and Oncompass Medicine to develop oncology NGS workflows for buyer consortium of seven major European hospitals

18.5.2022

HELSINKI, Finland May 2022. Euformatics, BC Platforms and Oncompass Medicine formed a partnership to bid for the development of standardized

Read more

Webinar | NGS test validation – Gathering evidence from bioinformatic data

6.5.2022

Go to recorded webinar. Next Generation Sequencing (NGS) relies on several quite distinct steps, all with potential effect on the patient

Read more

OmnomicsNGS Version 2.7 – Explore more NGS features with us

28.4.2022

The omnomicsNGS variant interpretation tool for annotation, classification and reporting has been upgraded to its latest version 2.7 this week in an

Read more

PRESS RELEASE | Viafet Genomics Laboratory partners with Euformatics to deliver carrier screening and clinical diagnostics in UAE using Next Generation Sequencing.

22.4.2022

HELSINKI, Finland, April 2022. Viafet Genomics Laboratory, a leading laboratory in the field of human genetics in The United Arab Emirates has

Read more

PRESS RELEASE | Omnomics Suite selected as the tool for quality control and variant interpretation for genetic tests with more than 3000 genes by Genetyca ICM in Portugal.

29.3.2022

HELSINKI, Finland, March 2022. Genetyca ICM SA, a leading laboratory in the field of human genetics in Portugal, has selected the Euformatics

Read more

PRESS RELEASE | Euformatics omnomicsNGS for clinical genomic variant interpretation now a CE-IVD device under IVDD (98/79/EC)

3.12.2021

HELSINKI, Finland, December 2021. Euformatics, Finnish bioinformatics software company, has today announced that its genomic variant interpretation

Read more

Previous page 1 … 6 7 8 9 10 … 18 Next page

Discover the potential of automated NGS data processing

Book a demo
Contact our experts

Gene Test Validation

Learn more

Variant Interpretation

Learn more

Euformatics logo

Accelerating the transition to precision medicine

More about us

  • Genomics Hub
    • Sample Quality Control
    • Assay Validation
    • Variant Interpretation
  • About us
    • Our mission
    • Team
    • Privacy Policy
  • Careers
  • News
  • Youtube
  • Twitter
  • LinkedIn

All rights reserved © Euformatics2026 | Website by Sivututka